Reduced ototoxicity by combined streptomycin-dihydrostreptomycin treatment of tuberculosis; follow-up report.
D003131:Combined Modality Therapy; D004096:Dihydrostreptomycin Sulfate; D004427:Ear Diseases; D005500:Follow-Up Studies; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin
STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy